false
Catalog
Research Greatest Hits- Updates in Buprenorphine T ...
View Presentation
View Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this webinar on improving medications for opioid use disorder practices, Dr. Mark Fishman presented on various topics. He highlighted the need to address major statistics associated with poor treatment outcomes, such as stimulant use, younger age, criminal justice involvement, and homelessness. Efforts should be made to offer medication for opioid use disorder (MOUD) in jails, with a focus on linking individuals to treatment upon release. Dr. Fishman emphasized the importance of using MOUD for patients with co-occurring substance use disorders, as it is safe and effective. He also discussed dosing strategies for buprenorphine and methadone, recommending rapid dose increases and dynamic dosing for maximum effectiveness. Finally, he touched on the challenges of offering extended-release naltrexone to opioid-dependent patients and suggested exploring strategies to increase its desirability and acceptability.
Keywords
improving medications
opioid use disorder practices
Dr. Mark Fishman
stimulant use
younger age
criminal justice involvement
homelessness
medication for opioid use disorder
MOUD
×
Please select your language
1
English